Chronic Kidney Disease (CKD) for the Nurse Practitioner Licensing Exam
Definition
- Chronic Kidney Disease (CKD): Progressive and irreversible loss of kidney function over at least 3 months, identified by reduced glomerular filtration rate (GFR) or evidence of kidney damage (e.g., albuminuria, abnormal imaging).
- Diagnosis:
- GFR <60 mL/min/1.73 m² for ≥3 months, or
- Evidence of kidney damage (e.g., albuminuria ≥30 mg/g, abnormal urinalysis).
Etiology
- Diabetes Mellitus: The most common cause of CKD due to chronic hyperglycemia, which damages glomeruli over time.
- Hypertension: Long-standing high blood pressure causes nephrosclerosis, contributing to progressive renal damage.
- Glomerulonephritis: Immune-mediated glomerular inflammation can result in chronic kidney damage.
- Polycystic Kidney Disease: A genetic disorder causing multiple renal cysts that lead to gradual renal failure.
- Other Causes:
- Chronic obstruction (e.g., kidney stones, benign prostatic hypertrophy).
- Prolonged use of nephrotoxic medications (e.g., NSAIDs).
Clinical Presentation
- Early Stages (Stages 1–3):
- Often asymptomatic with subtle signs such as hypertension or proteinuria.
- Fatigue and edema may occur due to fluid retention.
- Late Stages (Stages 4–5):
- Uremia: Symptoms include nausea, pruritus, fatigue, and confusion.
- Fluid Overload: Dyspnea, peripheral edema, and pulmonary edema.
- Anemia: Due to decreased erythropoietin production by the kidneys.
- Bone Disease: Renal osteodystrophy due to disrupted calcium-phosphorus metabolism.
Diagnosis
- Serum Creatinine and GFR: Used to assess kidney function.
- Urinalysis: Detects proteinuria and hematuria, important markers of kidney damage.
- Electrolytes: Advanced CKD often presents with hyperkalemia, hyperphosphatemia, and metabolic acidosis.
Management
- Control of Underlying Conditions:
- Diabetes: Tight glycemic control (HbA1c <7%).
- Hypertension: ACE inhibitors or ARBs to lower BP and reduce proteinuria (target <130/80 mmHg).
- Dietary Management:
- Protein and sodium restriction to manage fluid overload and nitrogenous waste.
- Complication Management:
- Anemia: Erythropoiesis-stimulating agents (ESAs) and iron supplements.
- Bone Disease: Phosphate binders, vitamin D analogs, and calcimimetics.
Complications
- Cardiovascular Disease: Leading cause of death in CKD patients.
- Electrolyte Imbalances: Hyperkalemia and metabolic acidosis can be life-threatening.
- Bone Disease: Increased fracture risk due to renal osteodystrophy.
Key Points
- CKD is diagnosed by reduced GFR (<60 mL/min/1.73 m²) or kidney damage for ≥3 months.
- Leading causes are diabetes, hypertension, and glomerulonephritis.
- Management focuses on controlling underlying conditions, dietary modifications, and managing complications like anemia and bone disease.
- Cardiovascular disease is the most common cause of death in CKD patients.